Status:
COMPLETED
Postoperative Epidural Analgesia in Spine Fusion Surgery
Lead Sponsor:
Assiut University
Conditions:
Pain
Eligibility:
All Genders
18-60 years
Phase:
PHASE2
Brief Summary
we aim to compare the analgesic effect of 0.125% bupivacaine HCL, 0.125% bupivacaine HCL + Morphine sulphate 3 mg, 0.125% bupivacaine HCL + Fentanyl 100 micro gram both at rest and mobilization maneuv...
Eligibility Criteria
Inclusion
- patients undergoing spine fusion surgery.
Exclusion
- Drug addiction. Intraoperative dural tear. Uses of opioids drug for any reason in the previous 48 hours. Mental dysfunction. Spinal fusion for any infectious or malignant causes.
Key Trial Info
Start Date :
December 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01838707
Start Date
December 1 2007
End Date
March 1 2013
Last Update
April 25 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University Hospital
Asyut, Egypt, 71111